Monopar Therapeutics Inc. (NASDAQ: MNPR) shares pick up ground Wednesday. The Wilmette, Illinois-based company, a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that its Phase ...